Skip to content

Use of v-TAC (venous to arterial conversion) software during the assessment for long term oxygen therapy (LTOT)

Use of v-TAC (venous to arterial conversion) software during the assessment for long term oxygen therapy (LTOT) - v-TAC during LTOT evaluation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00034264
Enrollment
50
Registered
2024-05-15
Start date
2024-06-14
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J96.1

Interventions

Group 1: Patients reffered for the evaluation of long term oxygen therapy (LTOT) can be included into the study. The titration process of different flow rates of supplementary oxygen will be done acco

Sponsors

Universitätsklinikum Mannheim
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Clinical necessity to evaluate the indication for LTOT - Written informed consent prior to study participation - The subject is willing and able to follow the procedures outlined in the protocol

Exclusion criteria

Exclusion criteria: -Hemodynamic instability - Impaired perfusion of peripheral limbs e. g. due to severe heart failure - Pregnant and lactating females - Patient has been committed to an institution by legal or regulatory order -The subject is mentally or legally incapacitated

Design outcomes

Primary

MeasureTime frame
To compare pO2 levels calculated by the v-TAC software from a single venous blood gas analysis and peripheral oxygen saturation at different rates of oxygen supplementation to pO2 levels in capillary blood samples.

Secondary

MeasureTime frame
To compare pCO2 and pH levels calculated by the v-TAC software from a single venous blood gas analysis and peripheral oxygen saturation at different rates of oxygen supplementation to pO2 levels in capillary blood samples.

Countries

Germany

Contacts

Public ContactTobias Müller

Universitätsklinikum Mannheim

tobias.mueller2@umm.de00496213838404

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026